Dr. Reddy’s to promote and distribute select Novartis products including the Voveran range, the Calcium range and Methergine in India
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
Merck is studying the Complete Response Letter and it is not related to the safety of gefapixant
Go-ahead for pivotal clinical trial which is expected to commence by March
Decisions reaffirm the ability of Biocon Biologics and Viatris to provide patient access to interchangeable Semglee
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
Since its inception, the company has either acquired or taken a majority stake in five companies
According to IQVIA, US sales of Everolimus (Afinitor) tablets were approximately US $ 675 million in the 12 months ending July 2021
Consequently, AstraZeneca India and Sun Pharma have now discontinued the Distribution Agreement signed in 2016 and have entered into a Transition Supply Agreement with effect from 28th May 2021
Subscribe To Our Newsletter & Stay Updated
